Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04756089 · ClinicalTrials.gov registry record · NA

Stimulation Therapy for Inducing Mothers

A NA study of Labor Pain and Induced; Birth, sponsored by Yale University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04756089 is a NA study of Labor Pain and Induced; Birth that has completed, run by Yale University. The registered enrollment target is 24 participants, below the 202-participant average among 14 other Labor Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04756089, a NA study of Labor Pain and Induced; Birth, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This is a pilot feasibility and acceptability study of a randomized clinical trial of pregnant women at 36 weeks of gestation and greater randomized to one of two arms at Yale New Haven Hospital: (1) Breast stimulation by hand or with an electronic breast pump (intervention) compared to (2) Exogenous oxytocin intravenous infusion (current standard of care, control). The pilot study will be randomized since one of the goals is to evaluate whether the idea of randomization would be acceptable to patients.

Interventions

  • DEVICE Electronic breast pump
  • OTHER Exogenous oxytocin intravenous infusion

Study Locations (1)

Connecticut

  • Yale New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-03-13
Est. Completion 2021-06-23
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04756089

The ClinicalTrials.gov registry entry for NCT04756089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 202-participant average among 14 other Labor Pain trials with a reported enrollment target (88% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Labor Pain appearing as the primary indexed condition, and to 2 interventions - of which Electronic breast pump is the first listed.

NCT04756089 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04756089 about?

NCT04756089 is a clinical study titled "Stimulation Therapy for Inducing Mothers". This is a pilot feasibility and acceptability study of a randomized clinical trial of pregnant women at 36 weeks of gestation and greater randomized to one of two arms at Yale New Haven Hospital: (1) Breast stimulation by hand or with an electronic breast pump (intervention) compared to (2) Exogenou...

What is the current status of trial NCT04756089?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-03-13. Estimated completion is 2021-06-23.

What conditions does trial NCT04756089 study?

This clinical trial studies the following conditions: Labor Pain, Induced; Birth, Labor Long, Breast Pumping, Lactation Induced.

What interventions are being tested in trial NCT04756089?

The interventions under investigation include: Electronic breast pump (DEVICE), Exogenous oxytocin intravenous infusion (OTHER).

Who is sponsoring clinical trial NCT04756089?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04756089 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.